Search
for
Sort by
Research 151–180 of 1000+
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- The Rotterdam Study: 2016 objectives and design update
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- The Rotterdam Study: 2018 update on objectives, design and main results
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- How to diagnose a lipodystrophy syndrome
- Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Hyperplasia of the Subcutaneous Adipose Tissue Is the Primary Histopathologic Abnormality in Lipedematous Scalp
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- PLAU and SerpinB2 role in apoptosis in leprosy
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Green hair discoloration due to selenium sulfide
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Case 21-2012
- Common pathologic pathways: A single prescription dream?
- Complications of liver transplantation: A perioperative perspective
- Acne
- Cross-sex hormone therapy for gender dysphoria
- Seborrheic Dermatitis: Three Novel Trichoscopic Signs and Its Correlation to <i>Malassezia</i> sp. Colonization
- Poster Abstracts
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- Dermatoses of pregnancy
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Non-hemorrhage-related adverse effects of rivaroxaban
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma